Cite
Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis.
MLA
Yakout, Ibrahim Abdelnasar, et al. “Efficacy of Metformin Drug in Preventing Metabolic Syndrome Associated with Androgen Deprivation Therapy (ADT) in Prostate Cancer Patients: A Systematic Review and Meta-Analysis.” Seminars in Oncology, vol. 51, no. 5–6, Oct. 2024, pp. 163–74. EBSCOhost, https://doi.org/10.1053/j.seminoncol.2024.10.001.
APA
Yakout, I. A., Gallab, M. M., Mohamed, D. A., Hamdar, H., I Ibrahim, S., Mohamed, A., Abdelshafi, A., & Abd-ElGawad, M. (2024). Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis. Seminars in Oncology, 51(5–6), 163–174. https://doi.org/10.1053/j.seminoncol.2024.10.001
Chicago
Yakout, Ibrahim Abdelnasar, Mohamed Mustafa Gallab, Daie AbdelRahman Mohamed, Hiba Hamdar, Sara I Ibrahim, Adham Mohamed, Abdelrahman Abdelshafi, and Mohamed Abd-ElGawad. 2024. “Efficacy of Metformin Drug in Preventing Metabolic Syndrome Associated with Androgen Deprivation Therapy (ADT) in Prostate Cancer Patients: A Systematic Review and Meta-Analysis.” Seminars in Oncology 51 (5–6): 163–74. doi:10.1053/j.seminoncol.2024.10.001.